First published 9/28/2026, 8:19:15 AM · Last updated 9/28/2026, 8:19:15 AM

Comparison of objective sleep variables in schizophrenia with comorbid insomnia treated with dual orexin receptor antagonists versus benzodiazepine receptor agonists

A Wiley journal article comparing objective sleep variables in people with schizophrenia and comorbid insomnia treated with dual orexin receptor antagonists versus benzodiazepine receptor agonists. The supplied excerpt contains only publisher and content-type information and provides no study results or details.

Categories: public-health, science-and-space

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 2/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 2/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 2/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 5/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The title indicates a comparison of two insomnia treatments in schizophrenia, but no results were provided in the excerpt.

Sources

Comparison of objective sleep variables in schizophrenia with comorbid insomnia treated with dual orexin receptor antagonists versus benzodiazepine receptor agonists

Report an issue